By interacting with tumor-suppressor proteins, such as p53 and pRb, PyLT-Ag can promote mechanisms that can contribute to tumor initiation and progression, i.e., uncontrolled proliferation and genomic instability [26,27,28]. This evidence concerns the gene TP53 and neoplasm.